Equities

Astec Lifesciences Ltd

Astec Lifesciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,233.80
  • Today's Change8.80 / 0.72%
  • Shares traded25.21k
  • 1 Year change-8.61%
  • Beta0.4857
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company has also developed capabilities and infrastructure which enables it to undertake contract development and manufacturing services for a diverse range of agrochemicals, catering to the needs of global innovators in the sector. Its products & solutions include agrochemical actives, intermediates and specialty chemicals, and contract development and manufacturing operations. The Company's agrochemical actives include triazole fungicides, herbicides and insecticides. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries including the United States and countries across Europe, West Asia, South-East Asia and Latin America and Africa. The Company has approximately four manufacturing plants, which are located in Mahad, Maharashtra.

  • Revenue in INR (TTM)3.85bn
  • Net income in INR-784.59m
  • Incorporated1994
  • Employees421.00
  • Location
    Astec Lifesciences LtdGodrej One, 3rd Floor, Pirojshanagar,, EMUMBAI 400079IndiaIND
  • Phone+91 2 225188010
  • Fax+91 2 222618289
  • Websitehttps://www.astecls.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Gocl Corporation Ltd6.91bn723.42m21.31bn376.0029.46--24.453.0914.6014.60139.34--------18,368,160.00--4.09--4.7823.6325.0710.4718.50---0.2441--24.62-22.506.05-77.153.542.4714.87
Platinum Industries Ltd-100.00bn-100.00bn21.61bn104.00------------------------------------------------14.22--15.36------
Yasho Industries Ltd6.16bn406.91m22.47bn818.0054.87--35.033.6535.9335.93542.93--------7,532,142.00--9.05--15.6635.8332.626.608.35--3.72--0.7963-11.6111.78-14.6337.2658.12--
Apcotex Industries Limited11.83bn565.60m22.73bn565.0040.21--25.121.9210.9010.90228.14--------20,946,130.00--11.06--14.9730.0925.014.787.66--5.42--36.294.1312.44-50.082.944.5312.89
Tatva Chintan Pharma Chem Ltd3.85bn260.59m23.09bn689.0087.77--44.146.0011.2511.25165.78--------5,582,076.00--10.54--14.6154.9843.966.7814.43--8.47--5.17-7.1113.79-33.278.1267.37--
Astec LifeSciences Limited3.85bn-784.59m24.20bn421.00------6.29-40.02-40.02196.20--------9,137,879.00--4.71--9.7322.4729.17-20.386.38---3.54--6.49-27.061.24-283.57--20.75--
Panama Petrochem Ltd.24.98bn1.99bn24.25bn164.0012.16--11.570.970732.9632.96412.84--------152,316,500.00--15.23--23.3516.4719.717.988.95--14.56--17.804.8013.17-16.2330.3416.2342.29
India Pesticides Ltd6.99bn632.20m24.28bn949.0038.32--30.753.475.505.5060.59--------7,369,126.00--------42.35--9.04----16.46-----23.11---57.99------
Owais Metal and Mineral Processing Ltd800.47m154.66m24.36bn25.00157.5335.66146.5230.448.518.5144.0237.58----------------31.57--19.32--2.5513.470.1651------12,258.88------
Xpro India Limited4.73bn466.06m24.98bn211.0051.57--43.525.2821.9821.98223.91--------22,419,500.00--7.95--11.1031.4227.169.856.57--12.34-----8.926.06-3.2780.1147.17--
Vishnu Chemicals Ltd12.51bn1.03bn25.96bn464.0025.03--18.742.0815.8315.83192.37--------26,955,710.00--8.32--13.7532.3434.298.237.48--4.65--2.43-12.829.53-25.9732.9236.578.45
Jubilant Industries Ltd12.63bn344.21m26.40bn4.0078.45--53.152.0922.3321.68829.30--------3,156,657,000.00--5.28--13.1638.8933.152.732.93--5.40--0.00-14.9117.53-44.69--22.73--
Insecticides (India) Ltd19.83bn1.22bn26.81bn1.62k21.93--17.671.3541.2941.29670.05--------12,279,370.00--6.18--10.5827.6822.426.165.63--17.70--7.959.1610.5361.94-3.585.2717.61
Nilkamal Ltd31.56bn1.08bn27.79bn3.64k25.70--12.380.880572.4472.442,114.93--------8,679,698.00--6.53--8.0442.5137.593.434.41--5.48--21.472.096.23-8.730.82436.369.00
Data as of Sep 20 2024. Currency figures normalised to Astec Lifesciences Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

6.21%Per cent of shares held by top holders
HolderShares% Held
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Aug 2024468.59k2.39%
Motilal Oswal Asset Management Co. Ltd.as of 30 Sep 2023197.80k1.01%
Norges Bank Investment Managementas of 31 Dec 2023187.18k0.96%
Tata Asset Management Pvt Ltd.as of 31 Aug 2024177.93k0.91%
ICICI Prudential Asset Management Co. Ltd.as of 31 Aug 2024138.63k0.71%
Dimensional Fund Advisors LPas of 05 Sep 202441.49k0.21%
SSgA Funds Management, Inc.as of 05 Sep 20244.19k0.02%
Dimensional Fund Advisors Ltd.as of 30 Jun 20241.91k0.01%
DFA Australia Ltd.as of 31 Jul 2024247.000.00%
American Century Investment Management, Inc.as of 05 Sep 2024150.000.00%
More ▼
Data from 30 Jun 2024 - 12 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.